Clinical immunosuppression
Ganzález, Z.A.
Boletin de la Asociacion Medica de Puerto Rico 73(4): 146-149
1981
ISSN/ISBN: 0004-4849 PMID: 6946781 Document Number: 700967
Document emailed within 1 workday
Related Documents
Castillo Lugo, J.A. 1995: Clinical and experimental immunosuppression Boletin de la Asociacion Medica de Puerto Rico 87(5-6): 106-108Górski, A.; Grieb, P. 1994: Cladribine (2-chloro-2'-deoxyadenosine): new perspectives in clinical immunosuppression Archivum Immunologiae et Therapiae Experimentalis 42(1): 11-12
Agarwal, D.; Chakravarty, J.; Sundar, S.; Gupta, V.; Bhatia, B.D. 2008: Correlation between clinical features and degree of immunosuppression in HIV infected children Indian Pediatrics 45(2): 140-143
Guttmann, R.D. 1994: Clinical immunosuppression, lymphocyte subsets, and host defense mechanisms Transplantation Proceedings 26(4): 1847
Dewilde, A. 2002: Virus and immunosuppression. 3d Seminar on Clinical Virology, Nancy, October 11 and 12, 2001 Annales de Biologie Clinique 60(4): 485-498
Rao, K.V.; Andersen, R.C. 1989: The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation Transplantation Proceedings 21(1 Part 2): 1652
Garin, A.M.; Gorbunova, V.A.; Bychkov, M.B.; Mindra, N.V.; Stenina, M.B.; Topchieva, S.V.; Treshchalina, E.M.; Chitiia, L.V.; Sdvizhkov, A.M.; Borisov, V.I.; Gurov, S.N.; Gershanovich, M.L.; Makhnova, E.V.; Nebol'sin, V.E. 2004: Results of a multicenter, phase-Ii clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy Voprosy Onkologii 50(2): 184-188
Monaco, A.P.; Wood, M.L.; Maki, T.; Gozzo, J.J. 1989: Future strategies in immunosuppression: problems and potential for the induction of specific unresponsiveness to organ allografts in clinical transplantation Transplantation Proceedings 21(6): 3939-3942
Knight, R.J.; Kurrle, R.; McClain, J.; Racenberg, J.; Baghdahsarian, V.; Kerman, R.; Lewis, R.; van Buren, C.T.; Kahan, B.D. 1994: Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor Transplantation 57(11): 1581-1588
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Wiedermann, G. 1970: Immunosuppression Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 21(8): 385-388
Djurković-Djaković, O. 1998: Toxoplasmosis and immunosuppression Srpski Arhiv Za Celokupno Lekarstvo 126(5-6): 197-203
Ellner, J.J. 1996: Immunosuppression in tuberculosis Infectious Agents and Disease 5(2): 62-72
Sachs, D.H. 1987: Specific immunosuppression Transplantation Proceedings 19(1 Pt 1): 123-127
Sasiain, M.C.; de la Barrera, S. 1989: Immunosuppression in leprosy Medicina 49(3): 213-215
SoRelle, R. 2003: Immunosuppression in myocarditis Circulation 107(6): E9010-E9011
Goust, J.M.; Stevenson, H.C.; Galbraith, R.M.; Virella, G. 1990: Immunosuppression and immunomodulation Immunology Series 50: 481-498
Charco, R.; Allende, H.; Margarit, C. 1996: Rejection and immunosuppression Gastroenterologia y Hepatologia 19(8): 419-426
Lyle, L.R.; Parker, C.W. 1974: New approaches to immunosuppression Federation Proceedings 33(8): 1889-1893
Green, C.J. 1981: Immunosuppression with cyclosporin A: a review Diagnostic Histopathology 4(2): 157-174